Impact Features
Dynamic teams of physicians, researchers, patients, and patient advocates work together in each RDCRN consortium to advance rare diseases research. This page collects feature articles highlighting both the work of the RDCRN consortia and the people behind that work. Choose the consortium acronym at the top of the page to view features articles related to that consortium.
October 28, 2024
Researchers from MGNet harnessed artificial intelligence to develop a new, automated tool for neuromuscular assessments in myasthenia gravis.
October 28, 2024
Researchers from MGNet harnessed artificial intelligence to develop a new, automated tool for neuromuscular assessments in myasthenia gravis.
October 28, 2024
Researchers from MGNet harnessed artificial intelligence to develop a new, automated tool for neuromuscular assessments in myasthenia gravis.
January 29, 2024
The Rare Diseases Act of 2002 (H.R. 4013) enacted the establishment of the Rare Diseases Clinical Research Network (RDCRN) in 2003.
August 22, 2023
February 25, 2022
Felipe Polo-Wood is an innovator—both in his work as an IT consultant and as a patient with myasthenia gravis (MG), a chronic autoimmune…
February 25, 2022
Linda Kusner, PhD, is a research professor of pharmacology, physiology, genomics, and precision medicine at the George Washington University School…